Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets

FHS
May 23, 2024
12:02 pm

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Curtis Nicholson as Director of Sales for Europe, Middle East, and Africa (EMEA). Curtis’ appointment will strengthen the Company’s market position in these regions as it progresses ambitious plans for future growth and commercial success.

COX-2 Inhibitor Added to Levonorgestrel Improved Emergency Contraception Efficacy

Taking the oral cyclo-oxygenase (COX)-2 inhibitor piroxicam in combination with levonorgestrel improved emergency contraception efficacy versus levonorgestrel alone, with no additional adverse events, a randomized

August 17, 2023

FDA accepts Mesoblast’s latest BLA for paediatric GvHD cell therapy – Pharmaceutical Technology

Remestemcel-L is a stem cell therapy developed with the mesenchymal stem cells (MSC) derived from the bone marrow of an unrelated donor. Credits: ArtemisDiana/Shutterstock.com Mesoblast

July 23, 2024

FDA priority review advances Atara’s tabelecleucel for viral infection – Pharmaceutical Technology

Tabelecleucel is an allogenic, T cell immunotherapy designed to identify and eliminate EBV-infected cells. Credits: FrentaN/Shutterstock.com Atara Biotherapeutics has announced that the US Food and

July 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.